MedinCell S.A.
Develops long-acting injectable therapies using proprietary technology to impact global health.
MEDCL | PA
Overview
Corporate Details
- ISIN(s):
- FR0004065605
- LEI:
- 969500R79U6PXCL2FF46
- Country:
- France
- Address:
- 3 RUE DES FRERES LUMIERE, 34830 JACOU
- Website:
- https://www.medincell.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
MedinCell S.A. is a clinical and commercial-stage pharmaceutical company specializing in the development of long-acting injectable (LAI) therapies. Leveraging its proprietary drug delivery technology, the company develops a diverse portfolio of controlled-release products across various therapeutic areas. This innovative approach is designed to enhance treatment efficacy, improve patient compliance, and reduce the overall burden of care by providing sustained therapeutic effects from a single injection. MedinCell collaborates with global pharmaceutical partners to advance its pipeline and address unmet medical needs, with a core mission to impact global health by making treatments more efficient and accessible.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-22 07:30 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 359.5 KB | ||
| 2025-09-22 07:30 |
Regulatory News Service
Inside Information / Other news releases
|
English | 263.8 KB | ||
| 2025-09-12 07:30 |
Board/Management Information
Informations privilégiées / Autres communiqués
|
French | 189.0 KB | ||
| 2025-09-12 07:30 |
Board/Management Information
Inside Information / Other news releases
|
English | 178.3 KB | ||
| 2025-09-10 21:41 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 171.5 KB | ||
| 2025-09-10 21:41 |
Regulatory News Service
Inside Information / Other news releases
|
English | 168.1 KB | ||
| 2025-06-17 17:45 |
Annual / Quarterly Financial Statement
Inside Information / News release on accounts, results
|
English | 405.2 KB | ||
| 2025-06-17 17:45 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 395.7 KB | ||
| 2025-06-10 18:00 |
Report Publication Announcement
Inside Information / Other news releases
|
English | 185.6 KB | ||
| 2025-06-10 18:00 |
Report Publication Announcement
Informations privilégiées / Autres communiqués
|
French | 192.0 KB | ||
| 2025-06-06 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
|
French | 183.7 KB | ||
| 2025-05-28 18:00 |
Report Publication Announcement
Informations privilégiées / Autres communiqués
|
French | 183.1 KB | ||
| 2025-05-28 18:00 |
Regulatory News Service
Inside Information / Other news releases
|
English | 156.6 KB | ||
| 2025-05-28 17:45 |
Regulatory News Service
Inside Information / Other news releases
|
English | 220.0 KB | ||
| 2025-05-28 17:45 |
Earnings Release
Informations privilégiées / Autres communiqués
|
French | 218.7 KB |
Automate Your Workflow. Get a real-time feed of all MedinCell S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for MedinCell S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-02 | N/A | Other | Sell | 60,000 | 600,006.00 EUR |
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
